Meet Our Team
Les Dorfman, MD
Professor, Neurology and Neurological Sciences
Director, Residency Program in Clinical Neurophysiology
Director, Stanford Neurodiagnostic Laboratories
Director, SHC/LPCH Evoked Potential Laboratories and Electromyography Laboratories
Director, Stanford Multiple Sclerosis
Dr. Leslie Dorfman has been on the staff at Stanford for more than 30 years, and specializes in clinical neurophysiology, multiple sclerosis, and electromyography.
Dr. Dorfman received his M.D. from Albert Einstein College of Medicine in 1968. He completed residencies at Greenwich Hospital in 1970 and at Stanford in 1973. In 1974 he did fellowships at the National Hospital in London and the Mayo Clinic in Rochester, MN.
He is Board Certified in Clinical Neurophysiology by the American Board of Psychiatry and Neurology, Electrodiagnostic Medicine by the American Board of Electrodiagnostic Medicine, and Neurology by the American Board of Psychiatry and Neurology.
Dr. Dorfman is a past president of the American Association for Electrodiagnostic Medicine, the AAEM Foundation for Research and Education, and the Association of California Neurologists. He has also been a Director of the American Board of Electrodiagnostic Medicine, and has served on the Clinical Advisory Board of the Silicon Valley Chapter of the Multiple Sclerosis Society.
Dr. Dorfman's research interests include the clinical electrophysiology of the peripheral and central nervous systems, including nerve conduction velocity; electromyography (EMG); and visual, auditory and somatosensory evoked potentials. He also studies the application of digital signal processing techniques in clinical neurophysiology for the diagnosis of neurological disorders, and for neurological rehabilitation.
He is also interested in implementing new methodologies for teaching clinical neuroscience to undergraduate, graduate and medical students, residents and fellows.
Jeffrey Dunn, MD
Associate Professor, Neurology and Neurological Sciences Director, Stanford Multiple Sclerosis Center
Dr. Dunn serves as Associate Director of the Stanford MS Center and Division Chief of Clinical Neuroimmunology. He specializes in the diagnosis, treatment and research of neuroimmunologic disorders, including Multiple Sclerosis, Neuromyelitis Optica, transverse myelitis, optic neuritis and clinically isolated syndromes. Recognized as a national leader in this field, Dr. Dunn is an elected member of the MS section executive committee of the American Academy of Neurology, and Chairman of the AAN MS education taskforce. His research interests focus on collaborative efforts to identify biomarkers of disease activity and predictors of treatment response in translational investigations of human tissue, and in the study of CNS demyelinating disease in non-traditional ethnic populations. He has been the Principal Investigator of numerous Phase II and Phase III pivotal trials to identify new and emerging treatments for Multiple Sclerosis. Dr. Dunn is the recipient of the Arthur L. Bloomfield Award in recognition of Excellence in teaching Clinical Medicine, the Lysia Forno award winner for teaching excellence of Neurology housestaff, and is recognized as one of “America’s Top Physicians” by the Consumer Research Council of America.
May Han, MD
Assistant Professor, Neurology & Neurological Sciences
Dr. Han is a Clinician-Scientist whose research focuses on identification of biomarkers and therapeutic targets in Multiple Sclerosis and demyelinating diseases. She utilizes Systems Biology approach such as proteomics and transcriptomics. She received her medical degree in Myanmar and completed Neurology residency at University of Washington in Seattle. She did a Translational Fellowship in Neuroimmunology at Stanford with Dr. Steinman. She joined the Neurology department and MS Center in 2009.
Lawrence Steinman, MD
Professor, Neurology & Neurological Sciences
Professor, Pediatrics
Dr. Steinman’s research focuses on what provokes relapses and remissions in MS and the nature of the genes that serve as a brake on brain inflammation in his quest for a vaccine against multiple sclerosis. He has taken several therapies from the bench to the bedside, including work directly related to the development of natalizumab, and two experimental therapies, statins and DNA vaccines, are in trials. Dr. Steinman founded two biotech companies, Neurocrine Biosciences and Bayhill Therapeutics, and served on the board of directors at Centocor. He received the John M. Dystel Prize in 2004 and has twice been awarded a Javits Neuroscience Award for his work. A graduate of Harvard School of Medicine, Dr. Steinman has been on the Stanford faculty since 1980.
Raymond A. Sobel, MD
Professor, Pathology (Neuropathology)
Dr. Sobel is a board certified neuropathologist with a longstanding research interest in immune responses in the brain. He received his MD from the University of California San Francisco and was trained in Anatomic and Neuropathology at UCSF, UC Davis and Stanford. Following a fellowship in Immunopathology at the Massachusetts General Hospital he served on the faculty at MGH and Harvard Medical School. Dr. Sobel came to Stanford in 1992 and is the neuropathologist at the Palo Alto Veterans’ Affairs Health Care System. He is the Editor-in-Chief of the Journal of Neuropathology and Experimental Neurology and is the current President of the American Association of Neuropathologists (2011-2012). His research focuses on mechanisms of MS pathogenesis and studying the animal model of MS, experimental autoimmune encephalomyelitis, with many collaborators.
Y. Joyce Liao, MD, PhD
Assistant Professor - Med Center Line, Ophthalmology
Dr. Liao is an assistant professor of Ophthalmology at Stanford. She played a key role in the creation of the Stanford Center for Vision and Blindness Prevention—a group of vision scientists spanning a range of disciplines. The center’s goal is to develop practical solutions for restoring vision and precluding blindness.
Dr. Liao attended Harvard for her undergraduate studies and the University of California, San Francisco, for her MD and PhD. She completed neurology training at Stanford and then specialized in neuroophthalmology because she wanted to attack challenging clinical problems that lack effective treatments.
Alexandra Goodyear, MD
MS/Clinical Neuroimmunology Fellow
Dr. Goodyear completed her undergraduate education at Brown University and then began her medical career with two years of public health work in Senegal, West Africa with the Peace Corps. Upon returning, she began a joint degree with Tufts University Medical School and The Fletcher School of Law and Diplomacy. During medical school, Dr. Goodyear was a representative on the Medical Education Committee, the Global Health Interest Group Co-chair, and became a certified Mediator. From 2007-2011 Dr. Goodyear underwent her Internship and Neurology Residency at Stanford University Medical Center and was elected Chief Resident by faculty for her last year of residency. In 2011 Dr. Goodyear was awarded the Sylvia Lawry Clinical Trials Fellowship by the MS Society and became the first Stanford Neurology Fellow. During her two year fellowship, Dr. Goodyear looks forward to completing a Masters Degree in Epidemiology, assisting in the multiple clinical trials that Stanford conducts, and pursuing MS and NMO research.
Jong-Mi Lee, NP
Nurse Practitioner
Jong-Mi joined the Multiple Sclerosis Team June 2008. She previously worked as staff nurse on B3, Neurosurgical Unit at Stanford Hospital and Clinics. She graduated from University of California at Berkeley with a Bachelor of Arts in Legal Studies and from the Family Nurse Practitioner program at Samuel Merritt College with a Master of Science in Nursing.